250 related articles for article (PubMed ID: 25199779)
1. Understanding variability in posaconazole exposure using an integrated population pharmacokinetic analysis.
Dolton MJ; Brüggemann RJ; Burger DM; McLachlan AJ
Antimicrob Agents Chemother; 2014 Nov; 58(11):6879-85. PubMed ID: 25199779
[TBL] [Abstract][Full Text] [Related]
2. Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects.
Kraft WK; Chang PS; van Iersel ML; Waskin H; Krishna G; Kersemaekers WM
Antimicrob Agents Chemother; 2014 Jul; 58(7):4020-5. PubMed ID: 24798274
[TBL] [Abstract][Full Text] [Related]
3. Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration.
Dolton MJ; Ray JE; Chen SC; Ng K; Pont L; McLachlan AJ
Antimicrob Agents Chemother; 2012 Nov; 56(11):5503-10. PubMed ID: 22890761
[TBL] [Abstract][Full Text] [Related]
4. An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers.
Chen L; Krekels EHJ; Heijnen AR; Knibbe CAJ; Brüggemann RJ
Drugs; 2023 Jan; 83(1):75-86. PubMed ID: 36607589
[TBL] [Abstract][Full Text] [Related]
5. Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteers.
Brüggemann RJ; van Luin M; Colbers EP; van den Dungen MW; Pharo C; Schouwenberg BJ; Burger DM
J Antimicrob Chemother; 2010 Oct; 65(10):2188-94. PubMed ID: 20667889
[TBL] [Abstract][Full Text] [Related]
6. A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole.
van Iersel MLPS; Rossenu S; de Greef R; Waskin H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712663
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.
Krishna G; Moton A; Ma L; Medlock MM; McLeod J
Antimicrob Agents Chemother; 2009 Mar; 53(3):958-66. PubMed ID: 19075045
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome.
Vehreschild JJ; Müller C; Farowski F; Vehreschild MJ; Cornely OA; Fuhr U; Kreuzer KA; Hallek M; Kohl V
Eur J Clin Pharmacol; 2012 Jun; 68(6):987-95. PubMed ID: 22286158
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic/pharmacodynamic profile of posaconazole.
Li Y; Theuretzbacher U; Clancy CJ; Nguyen MH; Derendorf H
Clin Pharmacokinet; 2010 Jun; 49(6):379-96. PubMed ID: 20481649
[TBL] [Abstract][Full Text] [Related]
10. Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children.
Boonsathorn S; Cheng I; Kloprogge F; Alonso C; Lee C; Doncheva B; Booth J; Chiesa R; Irwin A; Standing JF
Clin Pharmacokinet; 2019 Jan; 58(1):53-61. PubMed ID: 29679234
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.
Sansone-Parsons A; Krishna G; Martinho M; Kantesaria B; Gelone S; Mant TG
Pharmacotherapy; 2007 Jun; 27(6):825-34. PubMed ID: 17542765
[TBL] [Abstract][Full Text] [Related]
12. A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication.
Elkayal O; Spriet I; Uyttebroeck A; Colita A; Annaert P; Allegaert K; Smits A; Van Daele R; Dreesen E
Ther Drug Monit; 2021 Aug; 43(4):512-518. PubMed ID: 33560094
[TBL] [Abstract][Full Text] [Related]
13. Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men.
Krishna G; Sansone-Parsons A; Kantesaria B
Curr Med Res Opin; 2007 Jun; 23(6):1415-22. PubMed ID: 17559737
[TBL] [Abstract][Full Text] [Related]
14. Meta-pharmacokinetic analysis of posaconazole following dosing of oral suspension, delayed-release tablet, and intravenous infusion in patients vs. healthy volunteers: Impact of clinical characteristics and race.
Chen L; Krekels EHJ; Dong Y; Chen L; Maertens JA; Blijlevens NMA; Knibbe CAJ; Brüggemann RJ
Int J Antimicrob Agents; 2023 Dec; 62(6):106995. PubMed ID: 37806462
[TBL] [Abstract][Full Text] [Related]
15. Population Pharmacokinetics of Posaconazole Tablets and Monte Carlo Simulations To Determine whether All Patients Should Receive the Same Dose.
Petitcollin A; Boglione-Kerrien C; Tron C; Nimubona S; Lalanne S; Lemaitre F; Bellissant E; Verdier MC
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848009
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation.
Kohl V; Müller C; Cornely OA; Abduljalil K; Fuhr U; Vehreschild JJ; Scheid C; Hallek M; Rüping MJ
Antimicrob Agents Chemother; 2010 Jan; 54(1):207-12. PubMed ID: 19858252
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men.
Courtney R; Radwanski E; Lim J; Laughlin M
Antimicrob Agents Chemother; 2004 Mar; 48(3):804-8. PubMed ID: 14982768
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
Krishna G; AbuTarif M; Xuan F; Martinho M; Angulo D; Cornely OA
Pharmacotherapy; 2008 Oct; 28(10):1223-32. PubMed ID: 18823218
[TBL] [Abstract][Full Text] [Related]
19. Effect of varying amounts of a liquid nutritional supplement on the pharmacokinetics of posaconazole in healthy volunteers.
Krishna G; Ma L; Vickery D; Yu X; Wu I; Power E; Beresford E; Komjathy S
Antimicrob Agents Chemother; 2009 Nov; 53(11):4749-52. PubMed ID: 19738015
[TBL] [Abstract][Full Text] [Related]
20. A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers.
Krishna G; Ma L; Martinho M; Preston RA; O'Mara E
J Antimicrob Chemother; 2012 Nov; 67(11):2725-30. PubMed ID: 22833639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]